跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,935 条关于
“LEO Foundation”
全部
7,935
临床试验
2,820
药物
245
机构
540
资讯
4,330
去年
LEO Pharma's Temtokibart Shows Promising Results in Phase 2b Trial for Moderate-to-Severe Atopic Dermatitis
去年
Global Clinical Trials Landscape for Alopecia Universalis Reveals Growing Research Activity Across Major Pharmaceutical Companies
去年
Newcastle University Researchers Identify Novel CD30-Targeting Combination Therapy to Overcome Immune Checkpoint Blockade Resistance in Melanoma
去年
Leo Pharma's Anzupgo Receives UK Approval for Chronic Hand Eczema
去年
Leo Cancer Care's Marie® Receives FDA 510(k) Clearance for Revolutionary Upright Particle Therapy Platform
去年
Delgocitinib Shows Promise for Adolescent Chronic Hand Eczema in Phase 3 Trial
5个月前
LEO Pharma's Enstilar Foam Receives NMPA Approval for Plaque Psoriasis Treatment in China
去年
Leo Pharma's Delgocitinib Filing Accepted in the US, Expanding JAK Inhibitor Market
去年
LEO Pharma Reports Double-Digit Growth Driven by Dermatology Portfolio
上个月
LEO Pharma Acquires Worldwide Rights to Dersimelagon for Up to $435 Million
第 1 页,共 433 页
上一页
下一页